Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss S T, Rotnitzky A
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
JAMA. 1996 Apr 17;275(15):1171-6.
To test the hypothesis that long-term lead accumulation, as reflected by levels of lead in bone (as opposed to blood which reflects recent lead exposure), is associated with an increased odds of developing hypertension.
Case-control study of participants in the Veterans Administration (now Department of Veterans Affairs) Normative Aging Study, a 30-year longitudinal study of men.
Of 1171 active subjects who were seen between August 1991 and December 1994, 590 (50%) participated in this investigation and had data on all variables of interest.
Hypertension was defined as taking daily medication for the treatment of hypertension or systolic blood pressure higher than 160 mm Hg or diastolic blood pressure of 96 mm Hg or higher during the time of examination. Levels of lead in the tibia (representing cortical bone) and the patella (representing trabecular bone) were measured in vivo with a K x-ray fluorescence (KXRF) instrument. Levels of lead in blood were measured by graphite furnace atomic absorption spectroscopy.
Blood lead levels were low, ranging from less than 0.05 to 1.35 micromol/L (<1 to 28 microgram/dL), with a mean (SD) of 0.30 (0.20) micromol/L (6.3[4.1] microgram/dL). Bone lead levels were similar to those described in other general populations. In comparison to nonhypertensives, mean levels of lead in blood and both tibia and patella bone lead levels were significantly higher in hypertensive subjects. In a logistic regression model of hypertensive status that began with age, race, body mass index, family history of hypertension, history of ethanol ingestion, pack-years of smoking, dietary sodium intake, dietary calcium intake, blood lead, tibia lead, and patella lead, the variables that remained after backward elimination were body mass index, family history of hypertension, and level of lead in the tibia. An increase from the midpoint of the lowest quintile to the midpoint of the highest quintile of tibia lead from 3 to 37 micrograms per gram of bone mineral was associated with an increased odds ratio of hypertension of 1.5.
Our findings suggest that long-term lead accumulation, as reflected by levels of lead in bone, may be an independent risk factor for developing hypertension in men in the general population.
检验如下假设,即骨铅水平所反映的长期铅蓄积(与反映近期铅暴露的血铅水平相对)与高血压发病几率增加相关。
对退伍军人管理局(现为退伍军人事务部)规范衰老研究的参与者进行病例对照研究,该研究是一项针对男性的为期30年的纵向研究。
在1991年8月至1994年12月期间接受检查的1171名现役受试者中,590名(50%)参与了本调查,并拥有所有感兴趣变量的数据。
高血压定义为在检查时正在服用治疗高血压的每日药物,或收缩压高于160 mmHg,或舒张压为96 mmHg或更高。使用K射线荧光(KXRF)仪器在体内测量胫骨(代表皮质骨)和髌骨(代表小梁骨)中的铅水平。血铅水平通过石墨炉原子吸收光谱法测量。
血铅水平较低,范围为低于0.05至1.35 μmol/L(<1至28 μg/dL),平均(标准差)为0.30(0.20)μmol/L(6.3[4.1]μg/dL)。骨铅水平与其他普通人群中描述的水平相似。与非高血压患者相比,高血压患者的血铅水平以及胫骨和髌骨的骨铅水平均值显著更高。在一个以年龄、种族、体重指数、高血压家族史、乙醇摄入史、吸烟包年数、饮食钠摄入量、饮食钙摄入量、血铅、胫骨铅和髌骨铅开始的高血压状态的逻辑回归模型中,向后剔除后剩下的变量是体重指数、高血压家族史和胫骨铅水平。胫骨铅从最低五分位数中点到最高五分位数中点每克骨矿物质从3微克增加到37微克与高血压比值比增加1.5相关。
我们的研究结果表明,骨铅水平所反映的长期铅蓄积可能是普通人群中男性患高血压的一个独立危险因素。